.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CF05_Flucloxacillin.Flucloxacillin .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CF05_Flucloxacillin.Flucloxacillin| name: | Flucloxacillin |
| ATC code: | J01CF05 | route: | oral |
| n-compartments | 1 |
Flucloxacillin is a beta-lactam antibiotic of the penicillin class, primarily used to treat infections caused by susceptible Gram-positive bacteria, including staphylococcal infections. It is widely used and approved for medical use today for conditions such as skin, bone, and joint infections, as well as pneumonia and endocarditis.
Pharmacokinetic parameters in healthy adult volunteers following oral administration of flucloxacillin capsules.
Drennan, PG, et al., & Chambers, ST (2021). Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid. British journal of clinical pharmacology 87(12) 4681–4690. DOI:10.1111/bcp.14887 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33963595
Öbrink-Hansen, K, et al., & Stilling, M (2022). Population Pharmacokinetics of Flucloxacillin In Bone and Soft Tissue- Standard Dosing is Not Sufficient to Achieve Therapeutic Concentrations. Pharmaceutical research 39(7) 1633–1643. DOI:10.1007/s11095-022-03197-y PUBMED:https://pubmed.ncbi.nlm.nih.gov/35233728
Barker, CIS, et al., & Standing, JF (2023). The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence. The Journal of antimicrobial chemotherapy 78(9) 2148–2161. DOI:10.1093/jac/dkad196 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37531085